Literature DB >> 20495776

[The development of deep brain stimulation as a putative treatment for resistant psychiatric disorders].

T E Schläpfer1, S Kayser.   

Abstract

Since approximately 10 years investigations have been carried out on the impact of deep brain stimulation (DBS) of treatment-resistant obsessive-compulsive disorders and depression. New fields of application are for Tourette's syndrome, substance abuse, dementia and anxiety. New functional, structural and molecular data have led to a new conceptualization of these disorders as dysfunctions of networks which process motivational and affective stimuli. DBS permits the selective and basically reversible modulation of such networks. So far adverse effects have been graded as marginal. In the field of treatment-resistant obsessive-compulsive disorders and depressive disorders uncontrolled studies have been published with initial satisfactory and concordant indications of the therapeutic effect of DBS in a variety of target areas of the brain. It is most important to provide a consistent interdisciplinary and durable development of concepts for a responsible use of DBS in patients with psychiatric disorders. Only in this way can the potentially most interesting therapeutic development of clinical psychiatry of the last 20 years be continued uninterrupted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495776     DOI: 10.1007/s00115-010-2941-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  31 in total

1.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

2.  Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases.

Authors:  U J Müller; V Sturm; J Voges; H-J Heinze; I Galazky; M Heldmann; H Scheich; B Bogerts
Journal:  Pharmacopsychiatry       Date:  2009-11-18       Impact factor: 5.788

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 4.  Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes.

Authors:  Matthis Synofzik; Thomas E Schlaepfer
Journal:  Biotechnol J       Date:  2008-12       Impact factor: 4.677

5.  Internal pallidal and thalamic stimulation in patients with Tourette syndrome.

Authors:  Marie-Laure Welter; Luc Mallet; Jean-Luc Houeto; Carine Karachi; Virginie Czernecki; Philippe Cornu; Soledad Navarro; Bernard Pidoux; Didier Dormont; Eric Bardinet; Jérôme Yelnik; Philippe Damier; Yves Agid
Journal:  Arch Neurol       Date:  2008-07

6.  Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments.

Authors:  Heather A Berlin; Holly Hamilton; Eric Hollander
Journal:  Mt Sinai J Med       Date:  2008 May-Jun

7.  Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression.

Authors:  Donald A Malone; Darin D Dougherty; Ali R Rezai; Linda L Carpenter; Gerhard M Friehs; Emad N Eskandar; Scott L Rauch; Steven A Rasmussen; Andre G Machado; Cynthia S Kubu; Audrey R Tyrka; Lawrence H Price; Paul H Stypulkowski; Jonathon E Giftakis; Mark T Rise; Paul F Malloy; Stephen P Salloway; Benjamin D Greenberg
Journal:  Biol Psychiatry       Date:  2008-10-08       Impact factor: 13.382

8.  Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.

Authors:  Thomas E Schlaepfer; Michael X Cohen; Caroline Frick; Markus Kosel; Daniela Brodesser; Nikolai Axmacher; Alexius Young Joe; Martina Kreft; Doris Lenartz; Volker Sturm
Journal:  Neuropsychopharmacology       Date:  2007-04-11       Impact factor: 7.853

9.  Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome.

Authors:  Jens Kuhn; Doris Lenartz; Jürgen K Mai; Wolfgang Huff; Sun-Hee Lee; Athanasios Koulousakis; Joachim Klosterkoetter; Volker Sturm
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

10.  Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation.

Authors:  D Servello; M Porta; M Sassi; A Brambilla; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09-10       Impact factor: 10.154

View more
  1 in total

1.  Microstructural abnormality in left nucleus accumbens predicts dysfunctional beliefs in treatment-resistant obsessive-compulsive disorder.

Authors:  Zhongchun Li; Weidong Ji; Deqiang Li; Xujuan Li; Wei Feng
Journal:  Med Sci Monit       Date:  2014-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.